Common Combined Oral Contraceptive Choice to Prescribe
Prescribe a combined oral contraceptive containing ethinylestradiol 35 micrograms or less with levonorgestrel or norethisterone as the first-line choice. 1
Rationale for First-Line Selection
The selection of this specific formulation is based on three key clinical priorities:
- Lowest effective estrogen dose: Pills containing ≤35 micrograms of ethinylestradiol minimize venous thromboembolism (VTE) risk while maintaining contraceptive efficacy 1
- Progestin safety profile: Levonorgestrel and norethisterone have the most favorable VTE risk profile compared to newer progestins 1
- Proven efficacy: These formulations demonstrate effective contraception when taken correctly with fewer side effects 1
Specific Dosing Considerations
The 20 microgram ethinylestradiol formulation with levonorgestrel represents the lowest effective dose available:
- This ultra-low dose combination results in fewer side effects while maintaining cycle control comparable to higher-dose pills 2
- Breakthrough bleeding remains a critical concern, as it is the most common reason for discontinuation, potentially leading women to switch to less effective methods or no contraception at all 2
Pre-Initiation Requirements
Before prescribing any combined hormonal contraceptive (CHC):
- Blood pressure measurement is mandatory 3
- No pelvic examination is required for initiation 3
- Assess cardiovascular risk factors, as estrogen-containing contraceptives increase VTE risk and should not be used in patients with conditions associated with cardiovascular events 4
Initiation Timing and Backup Contraception
- CHC can be started anytime if the provider is reasonably certain the patient is not pregnant 3
- If started >5 days after menses began: Require abstinence or barrier methods (condoms) for 7 days 3
- If started within 5 days of menses: No backup contraception needed 3
Critical Drug Interactions to Avoid
Category 3 interactions (use not recommended):
- Rifampin or rifabutin therapy significantly reduces COC efficacy 3, 5
- Certain anticonvulsants (phenytoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine) 3
- Lamotrigine levels may be reduced by CHCs, worsening seizure control 3
Common antibiotics do NOT reduce COC efficacy (broad-spectrum antibiotics, antifungals, antiparasitics are all Category 1) 3, 5
Alternative Progestin Considerations
While levonorgestrel/norethisterone remain first-line, certain clinical scenarios may warrant alternative progestins:
- Drospirenone-containing pills: More potent antiandrogenic properties, beneficial for acne, hirsutism, and polycystic ovary syndrome 6, 7
- Desogestrel, dienogest, or chlormadinone acetate: May be considered for specific dermatologic or menstrual indications 7
Common Pitfalls to Avoid
- Do not substitute therapeutically equivalent generic formulations for brand-name low-dose OCPs without consideration: Differences in bioavailability may interfere with efficacy and increase breakthrough bleeding, leading to discontinuation and unintended pregnancy 2
- Do not prescribe COCs to patients with migraine with aura: This is contraindicated due to stroke risk 7
- Do not overlook the 28/0 regimen option: Extended cycle regimens with fewer or no inactive pills may be preferred by some patients and can improve menstrual-related symptoms 1, 7